1. Home
  2. Detail

@mrlawalibeau2: صل وسلم على سيدنا محمد ﷺ ❤️ Qu’Allah prie sur notre Prophète Muhammad et le salue. Écris "AMINE" en commentaire#musulman #rappels_islam #doua #allah #madina

mr lawali beau gars🇳🇪🇳🇪
mr lawali beau gars🇳🇪🇳🇪
Open In TikTok:
Region: CI
Monday 02 November 2026 12:31:21 GMT
125
52
6
0

Music

Download

No Watermark .mp4 (1.31MB) No Watermark(HD) .mp4 (1.31MB) Watermark .mp4 (1.31MB) Music .mp3

Comments

zahra.ouattara82
Zahra Ouattara :
Paix et salut d'Allah sur lui ♥️♥️
2026-11-02 12:48:35
0
mme.kon971
Mme KONÉ :
SAW
2026-11-02 13:35:25
0
abdoulahialkasoum
abdoulahi.alkasoum.🇳🇪ggtl :
[Réconfortant][Réconfortant][Réconfortant]
2026-11-02 12:37:33
0
mrlawalibeau2
mr lawali beau gars🇳🇪🇳🇪 :
🥰🥰🥰
2026-11-02 12:34:03
0
gaidi.agali
Gaidi Agali :
🥰🥰🥰
2026-11-02 13:49:14
0
To see more videos from user @mrlawalibeau2, please go to the Tikwm homepage.

Other Videos

иди нахуй #идинах #кот #мем
иди нахуй #идинах #кот #мем
28 tuổi học lớp 11 không sợ hình học vì đã có trợ thủ đắc lực này #huonghoclai #chiase
28 tuổi học lớp 11 không sợ hình học vì đã có trợ thủ đắc lực này #huonghoclai #chiase
#westandwithmrpattlo #justiceformrpatlo #mrpattlo #westandwithmrpattlo
#westandwithmrpattlo #justiceformrpatlo #mrpattlo #westandwithmrpattlo
النجم #حسام_الرسام في حفل جديد 🎉🎇 الأوسكار العراقي.. خياركم المفضل للسهر 🌆 📞 للحجز: No1: +971 56 959 0011 No2: +971 56 775 1216 No3: +971 43 300 266 📍العنوان: Dubai - SHEIKH ZAYED - RD - THE H HOTEL - FIRST FLOOR.
النجم #حسام_الرسام في حفل جديد 🎉🎇 الأوسكار العراقي.. خياركم المفضل للسهر 🌆 📞 للحجز: No1: +971 56 959 0011 No2: +971 56 775 1216 No3: +971 43 300 266 📍العنوان: Dubai - SHEIKH ZAYED - RD - THE H HOTEL - FIRST FLOOR.
🚨 COMPOUNDED TIRZEPATIDE RECALLS — OCTOBER 2026 Two separate FDA Class II recalls involving compounded tirzepatide due to a lack of assurance of sterility. ⚠️ RECALL #1: APOTHECARY PHARMA, LLC 📍 Cary, North Carolina (503B outsourcing facility) Medication: Tirzepatide Injection Strength: 18 mg/mL Vial size: 4 mL multidose vial NDC: 85091-001-18 FDA Recall #: D-0036-2027 Recall initiated: September 24, 2026 AFFECTED LOT NUMBERS (22): AP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644. Beyond-use dates: October 7–November 26, 2026. ⚠️ RECALL #2: HOUSTON RX, LLC 📍 Houston, Texas (503A compounding pharmacy) Medication: Tirzepatide/Niacinamide Injection Strength: 20 mg/2 mg per mL Vial size: 2 mL FDA Recall #: D-0040-2027 Recall initiated: September 25, 2026 AFFECTED LOT NUMBER: TZN-080326-20/2-2 Beyond-use date: December 1, 2026. 🚨 Both recalls involve a lack of assurance of sterility. These recalls do NOT involve FDA-approved Mounjaro or Zepbound. If you use compounded tirzepatide, verify the source of your medication and check your lot number. If your medication is affected, do not use it. Contact your dispensing pharmacy or prescriber for guidance. Remember: The pharmacy dispensing your medication may not be the facility that originally compounded it. #TikTokCreatorSearchInsightsIncentive #compoundglp1 #MedicationRecall
🚨 COMPOUNDED TIRZEPATIDE RECALLS — OCTOBER 2026 Two separate FDA Class II recalls involving compounded tirzepatide due to a lack of assurance of sterility. ⚠️ RECALL #1: APOTHECARY PHARMA, LLC 📍 Cary, North Carolina (503B outsourcing facility) Medication: Tirzepatide Injection Strength: 18 mg/mL Vial size: 4 mL multidose vial NDC: 85091-001-18 FDA Recall #: D-0036-2027 Recall initiated: September 24, 2026 AFFECTED LOT NUMBERS (22): AP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644. Beyond-use dates: October 7–November 26, 2026. ⚠️ RECALL #2: HOUSTON RX, LLC 📍 Houston, Texas (503A compounding pharmacy) Medication: Tirzepatide/Niacinamide Injection Strength: 20 mg/2 mg per mL Vial size: 2 mL FDA Recall #: D-0040-2027 Recall initiated: September 25, 2026 AFFECTED LOT NUMBER: TZN-080326-20/2-2 Beyond-use date: December 1, 2026. 🚨 Both recalls involve a lack of assurance of sterility. These recalls do NOT involve FDA-approved Mounjaro or Zepbound. If you use compounded tirzepatide, verify the source of your medication and check your lot number. If your medication is affected, do not use it. Contact your dispensing pharmacy or prescriber for guidance. Remember: The pharmacy dispensing your medication may not be the facility that originally compounded it. #TikTokCreatorSearchInsightsIncentive #compoundglp1 #MedicationRecall


About

Legal